alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5129 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
                                H. R. 5129

  To reauthorize the Global Food Security Act of 2016, and for other 
                               purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 27, 2018

   Mr. Smith of New Jersey (for himself, Ms. McCollum, Mr. Royce of 
   California, Mr. Engel, Mr. Austin Scott of Georgia, Ms. Bass, Mr. 
Fortenberry, Mr. McGovern, Mr. Paulsen, Ms. DeLauro, Mr. Reichert, Mr. 
Smith of Washington, and Mr. Cicilline) introduced the following bill; 
         which was referred to the Committee on Foreign Affairs

_______________________________________________________________________

                                 A BILL

 
  To reauthorize the Global Food Security Act of 2016, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Global Food Security Reauthorization 
Act of 2018''.

SEC. 2. AMENDMENTS TO THE GLOBAL FOOD SECURITY ACT.

    (a) Statement of Policy Objectives.--Section 3(a)(6) of the Global 
Food Security Act of 2016 (22 U.S.C. 9302(a)(6)) is amended by 
inserting ``deworming programs,'' after ``diet diversification,''.
    (b) Relevant Federal Departments and Agencies.--Section 4(7) of 
such Act (22 U.S.C. 9303(7)) is amended by inserting ``the Inter-
American Foundation,'' after ``the United States Africa Development 
Foundation,''.
    (c) Authorization of Appropriations To Implement Global Food 
Security Strategy.--Section 6(b) of such Act (22 U.S.C. 9305(b)) is 
amended by striking ``fiscal years 2017 and 2018'' and inserting 
``fiscal years 2017 through 2021''.
    (d) Reports.--The matter preceding section 8(a)(1) of such Act (22 
U.S.C. 9307(a)(1)) is amended--
            (1) by striking ``Not later than 1 year and 2 years after 
        the date of the submission of the strategy required under 
        section 5(c),'' and inserting ``Not later than September 30, 
        2018, and annually thereafter through 2021,''; and
            (2) by striking ``for 2017 and 2018'' and inserting ``for 
        the preceding fiscal year''.

SEC. 3. AMENDMENT TO THE FOREIGN ASSISTANCE ACT OF 1961.

    Section 492(a) of the Foreign Assistance Act of 1961 (22 U.S.C. 
2292a(a)) is amended by striking ``fiscal years 2017 and 2018'' and 
inserting ``fiscal years 2017 through 2021''.
                                 <all>
```
Exhibit 10.2 Amendment to Primary License


Exhibit 10.2




THIS AMENDING AGREEMENT dated 31 July 2006 is between: 




1. 

IMPERIAL INNOVATIONS LIMITED (“Innovations”), a company incorporated in England and Wales whose principal place of business is at 12th Floor, Electrical Engineering Building; Imperial College, London SW7 2AZ; and 




2. 

CRONOS THERAPEUTICS LIMITED (“Licensee”), a company incorporated in England and Wales, whose principal place of business is at The London BioScience Innovation Centre, 2 Royal College Street, London NW1 OTU. 




WHEREAS Innovations, and the Licensee have entered into a Patent License Agreement dated 19th 




October 2005 (“Current Agreement”) for gene mapping technology and they now with to amend the 




Current Agreement as appears below.




IT IS AGREED AS FOLLOWS:




1. 

Status of this Agreement. This Amending Agreement is supplemental to the Current Agreement. Except as expressly amended by this Amending Agreement, the Current Agreement shall remain in full force and effect. Terms defined in the Current Agreement shall have the same meaning in this Amending Agreement, unless otherwise provided by this Amending Agreement. 




2. 

Extension. Innovations agrees to extend the Term of the Current Agreement as described in clause 9.2 of the Current Agreement. 




3. 

Commencement and Termination by Expiry. Clause 8.1 of the Current Agreement is amended by:




deleting the words “31st July 2006” and replacing them with the words “30 November 2006”.




4. 

Commercialization




Further to the commercialization terms set out in clause 5 of the Current Agreement, the Licensee shall also keep Innovations regularly updated on a monthly basis on the status of the Licensee’s commercial progress. 




5.

Termination




Notwithstanding clause 5.5 Imperial Innovations retains the right to terminate the license agreement on two weeks written notice prior to 30 November 2006.




AGREED by the Parties through their authorized signatories: 




			
	For and on behalf of 

	 
	For and on behalf of


	IMPERIAL INNOVATIONS LTD 

	 
	CRONOS THERAPEUTICS LTD


	 
	 
	 

	 
	 
	 

	/s/ Julian Smith



	 
	/s/ Satu Vainikka


	Signed 

	 
	Signed 


	 
	 
	 

	Julian Smith

	 
	Satu Vainikka


	Print name 

	 
	Print name


	 
	 
	 

	C.F.O.O.

	 
	CEO


	Title 

	 
	Title 


	 
	 
	 

	31st July, 2006

	 
	4/8/06


	Date 

	 
	Date
EXHIBIT 32





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Li-ion Motors Corp. (the “Company”)  on Form 10-Q for the quarter ended January 31, 2011, as filed with the Securities and Exchange  Commission on the date hereof (the “Report”),  I, Stacey Fling,  Chief  Executive Officer and Principal Financial Officer of the  Company,  certify, pursuant to 18 U.S.C. section 1350, as adopted  pursuant to section 906 of the  Sarbanes-Oxley Act of 2002, that to the best of my knowledge:





(1) The Report fully complies with the  requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The  information  contained in the Report  fairly  presents,  in all material  respects,  the  financial  condition  and result of  operations of the Company.





/s/ Stacey FlingStacey FlingChief Executive Officer andPrincipal Financial OfficerMarch 17, 2011
From: Tom Osborn [tgtcosborn@comcast.net]

Sent: Tuesday, June 07, 2011 11:24 AM

To: Hancy, Cindy Wang; "'dwreeves@rti.org.'"

Cc: fairchild.susan@epamail.epa.gov

Subject: Residual Risk Inquiry

- Fibertek

Attachments: Wool Fiberglass Modeling Sources by Co 6 7 11

- FiberTEK.xlsx

Attached is the spreadsheet with the information you requested. Please note that the aerial view is

attached to the spreadsheet. If you have any questions, please feel free to co ntact me.

Regards,



## Tom Osborn

863

- 899

- 1239 Cell

863

- 682

- 4448 Office
Fourth Court of Appeals

San Antonio, Texas

November 19, 2014

No. 04-14-00612-CV

David Allan EDWARDS,

Appellant

v.

SHERIFF OF COUNTY OF ATASCOSA,

Appellee

From the 81st Judicial District Court, Atascosa County, Texas

Trial Court No. 12-02-0185-CVA

Honorable Thomas F. Lee, Judge Presiding

O R D E R

On November 3, 2014, this court issued an order informing appellant that no reporter’s 

record had been taken based upon representations made to this court by both a court reporter and 

the trial court clerk. However, on November 18, 2014, a reporter’s record was filed in this court. 

Accordingly, it appears the appellate record in this appeal is now complete.

Therefore, appellant’s brief is due December 19, 2014. Appellant is reminded that 

although pro se litigant may be held to “less stringent” standards, a pro se litigant is still required 

to comply with the law and rules of procedure. Shull v. United Parcel Serv., 4 S.W.3d 46, 52-53 

(Tex. App.—San Antonio 1999, pet. denied). 

_________________________________

Sandee Bryan Marion, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 19th day of November, 2014.

___________________________________

Keith E. Hottle

Clerk of Court
EXHIBIT 32.1
                            CERTIFICATION PURSUANT TO
                                 18 U.S.C. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of NEXHORIZON COMMUNICATIONS,  INC. (the
"Company")  on Form 10-Q for the period ended June 30,  2008,  as filed with the
Securities and Exchange Commission on the date hereof (the "Report"),  I, Calvin
D. Smiley,  Sr., Chief Executive Officer and President of the Company,  certify,
pursuant  to 18  U.S.C.  1350,  as  adopted  pursuant  to  Section  906  of  the
Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

The  information  contained  in the  Report  fairly  presents,  in all  material
respects, the financial condition and results of operations of the Company.



Date: August 18, 2008



By:       /s/ Calvin D. Smiley, Sr.
         -----------------------------
         Calvin D. Smiley, Sr.
         Chief Executive Officer
         and President
<TABLE>
<CAPTION>

                                                 Exhibit 11


                                            WVS Financial Corp.
                               Statement Re Computation of Per Share Earnings

                                               Three Months Ended                Twelve Months Ended
                                                   June 30,                            June 30,
                                         -----------------------------       -----------------------------
                                            1998              1997              1998               1997
                                         -----------       -----------       -----------       -----------
<S>                                        <C>               <C>               <C>               <C>      
Weighted average common shares
  outstanding .....................        3,616,529         3,486,571         3,548,088         3,477,126

Average unearned ESOP shares ......          (65,069)          (95,392)          (75,760)         (107,330)
                                         -----------       -----------       -----------       -----------

Weighted average common shares
  and common stock equivalents
  used to calculate basic
  earnings per share ..............        3,551,460         3,391,179         3,472,328         3,369,796

Additional common stock equivalents
  (stock options) used to calculate
  diluted earnings per share ......           81,919           117,235           103,564           120,430
                                         -----------       -----------       -----------       -----------

Weighted average common shares and
  common stock equivalents used to
  calculate diluted earnings
  per share .......................        3,633,379         3,508,414         3,575,892         3,490,226
                                         ===========       ===========       ===========       ===========

Net income ........................      $   686,986       $   882,559       $ 3,491,752       $ 2,958,878
                                         ===========       ===========       ===========       ===========

Earnings per share:
  Basic ...........................      $      0.19       $      0.26       $      1.01       $      0.88
  Diluted .........................      $      0.19       $      0.25       $      0.98       $      0.85
                                         ===========       ===========       ===========       ===========

</TABLE>
Exhibit 10.1
   
    1. Transition Date.
 2. Post-Transition Date. Schedule 1




---



##### 



3. Continued Vesting.
 4. Other Benefits.
 5. Accrued Salary and Vacation.
 6. Transition Ending Date Benefits. Exhibit A
 7. Proprietary Information and Inventions.
 8. Other Work Activities.




---



##### 



9. Other Compensation or Benefits.
 General Compensation or Benefits
 Change in Control Compensation or Benefits
 Change in Control Benefits Prior to the Reassignment Date
 Change in Control Benefits After the Reassignment Date
 10. Return of Company Property




---



##### 



11. Nonsolicitation.
 12. Nondisparagement.
 13. Release.
 General Release
 Scope of Release
 Exceptions




---



##### 



14. ADEA Waiver.
 15. Section 1542 Waiver.
 A general release does not extend to claims which the creditor does
not know or suspect to exist in his or her favor at the time of
executing the release, which if known by him or her must have
materially affected his or her settlement with the debtor.
  16. Entire Agreement.




---



##### 



17. Successors and Assigns.
 18. Applicable Law.
 19. Severability; Waiver of Breach.
 20. Counterparts.
   Sincerely,
QUESTCOR PHARMACEUTICALS, INC.By:
    /s/ Don BaileyDon BaileyPresident & Chief Executive Officer UNDERSTOOD AND AGREED:/s/ George M. Stuart

George M. StuartDate: July 31, 2008
In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

No. 02-22-00185-CV

GABRIEL SANCHEZ, Appellant

V.

SPIRAL DINER & BAKERY, JOHN DOE,

JANE DOE, AND MANAGER JANE DOE,

Appellees

§

§

§

§

On Appeal from the 348th District Court

of Tarrant County (348-324573-21)

July 14, 2022

Memorandum Opinion by Justice Wallach

JUDGMENT

This court has considered the record on appeal in this case and holds that the 

appeal should be dismissed. It is ordered that the appeal is dismissed for want of 

jurisdiction.

SECOND DISTRICT COURT OF APPEALS

By _/s/ Mike Wallach__________________

 Justice Mike Wallach
EXHIBIT 32.02
***CERTIFICATION BY CHIEF FINANCIAL OFFICER***
     I, Theresa D. Becks, the Chief Financial Officer of Campbell & Company, Inc. as generalpartner, of Campbell Strategic Allocation Fund, L.P., certify that (i) the Form 10K for the yearended December 31, 2004 of Campbell Strategic Allocation Fund, L.P. fully complies with therequirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) theinformation contained in the Form 10K for the year ended December 31, 2004 fairly presents, in allmaterial respects, the financial condition and results of operations of Campbell StrategicAllocation Fund, L.P.       CAMPBELL STRATEGIC ALLOCATION FUND, L.P.  By: Campbell & Company, Inc., general partner      By: /s/ Theresa D. Becks       Theresa D. Becks   Chief Financial Officer   March 29, 2005
E 5
```

[Congressional Record Volume 158, Number 128 (Thursday, September 20, 2012)]
[Senate]
[Page S6545]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                    EXECUTIVE REPORTS OF COMMITTEES

  The following executive reports of nominations were submitted:

       By Mr. AKAKA for the Committee on Indian Affairs.
       *Kevin K. Washburn, of New Mexico, to be an Assistant 
     Secretary of the Interior.
       By Mr. LEAHY for the Committee on the Judiciary.
       William Joseph Baer, of Maryland, to be an Assistant 
     Attorney General.

  *Nomination was reported with recommendation that it be confirmed 
subject to the nominee's commitment to respond to requests to appear 
and testify before any duly constituted committee of the Senate.
  (Nominations without an asterisk were reported with the 
recommendation that they be confirmed.)

                          ____________________
```
Exhibit 31.2CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002I, William M. Scharninghausen, Chief Financial Officer of Vialta, Inc., certify that:1. I have reviewed this quarterly report on Form 10-Q of Vialta, Inc. (the “registrant”);2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report;3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report;4. The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:          (a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;          (b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and          (c) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourthfiscal quarter in the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financial reporting; and5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of the registrant’s board of directors (or persons performing the equivalent functions):          (a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize and report financial information; and          (b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.       Date:August 15, 2005   /s/ William M. Scharninghausen William M. Scharninghausen      Chief Financial Officer
***********************************************The “officially released” date that appears near the beginning of each opinion is the date the opinion will be published in the Connecticut Law Journal or the date it wasreleased as a slip opinion. The operative date for the beginning of all time periods fo r filing postopinion motions and petitions for certification is the “officially released” date appearing in the opinion.

All opinions are subject to modification and technical correction prior to official publication in the Connecticut Reports and Connecticut Appella te Reports. In the event of discrepancies between the adva nce release version of an opinion and the latest version appearing in the Connecticut Law Journal and subsequently in the Connecticut Reports or Connecticut Appellate Reports , the latest version is to
be considered authoritative.

The syllabus and procedural history accompanying the opinion as it appears in the Connecticut Law Journal and bound volumes of official repo rts are copyrighted by the Secretary of the State, Stat e of Connecticut, and may not be reproduced and distributed without the express written permission of the Commission on Official Legal Publications, Judicial Branch, State of Connecticut.
***********************************************BORELLI v. RENALDI—SECOND CONCURRENCE
D’AURIA, J., concurring. Although I join the majority opinion in full, I agree in part with observations JusticeEcker makes in part III of his dissenting opinion concerning the identifiable victim-imminent harm exception to governmental immunity. Specifically, I am skeptical that the doctrinal validity of this exception can be based on whether a plaintiff ‘‘was compelled to be at the location where the injury occurred . . . .’’ (Internal quotation marks omitted.) Strycharz v. Cady

, 323 Conn. 548, 576, 148 A.3d 1011 (2016), overruled in part on other grounds by Ventura v. East Haven , 330 Conn. 613, 199 A.3d 1 (2019). The appropriate doctrinal underpinnings and limits of this exception would beuseful to explore in a future case. I am satisfied, however, that the exception does not save the plaintiff’s

cause of action from defeat in this case.
The information contained in this file set includes documents referenced in the Technical Support 

Document other than EPA guidance documents and NMED reports. Those additional referenced 

documents can be found elsewhere within the docket. 

File List:

2007-11_SRP_Navajo_BART_Analysis_Report.pdf

Appendix_H_All_Sources_v5.xls

BART-Eligible_EGUs.xls

BRODE_CA.pdf

CALPUFF_status_update_Atkinson.pdf

Clarification on EPA-FLM Recommended settings_Fox_memo.pdf

Draft-ColoradoSupplementalBARTAnalysisCALPUFFProtocol-19August2010.pdf

EPRI 2008.pdf

FLAG_2010.pdf

FWS-NPS_Comments-NewMexicoRegionalHazeSIP-17AUG2010.pdf

Favale_Summary.pdf

Hardman et al 1998.pdf

Harrison_2005_estimating total sulfuric acid.pdf

IMPROVEEquationReview.pdf

IWAQMphase2.pdf

Measured Visibility Impariment IMPROVE monitors.xlsx

Measurements of ambient background ammonia Tombach.pdf

Moore-Update_on_IMPROVE_Equation_and_Natural.pdf

NM_summary_v4_Apr21_2007.doc

Q_and_A_for_Regional_Haze_8-03-06.pdf

RevisedIMPROVEAlgorithm3.doc

Sather et al-revised ammonia data.pdf

Summary%20of%20Comments_122105_final.pdf

TSD ref umbrella.pdf

WRAP BART eligible _Report_No_Appendices.doc

WRAP_RMC_BART_Protocol_Aug15_2006.pdf

acid mist emissions test report catalyst air management 264-001.pdf

calpuff_vistas_assessment_report_final.pdf

email Anita Lee Anthony Favale Hitachi.pdf

Re_ PM Speciation and SO3_Don_Shepherd.eml

revised SJGS #1 Dry-Bottom PC w FGD+FF PM speciation profile.xlsx

revised SJGS #2 Dry-Bottom PC w FGD+FF PM speciation profile.xlsx

revised SJGS #3 Dry-Bottom PC w FGD+FF PM speciation profile.xlsx

revised SJGS #4 Dry-Bottom PC w FGD+FF PM speciation profile.xlsx

NM San Juan EGU EI compare WRAP to actuals.xls

NM_SJGS_emission_calcs_for_CALPUFF.xls
Exhibit 99.2

CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Lawson Software, Inc. (the "Company") on Form 10-Q for the period ended February 28, 2003
as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert G. Barbieri, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| |  | /s/ ROBERT G. BARBIERIRobert G. Barbieri Executive Vice President and Chief Financial Officer
| |  | ---------------------------------------------------------------------------------------------
| |  | April 10, 2003                                                                               

A
signed original of this written statement required by Section 906 has been provided to Lawson Software, Inc. and will be retained by Lawson Software, Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.

---

QuickLinks